Skip to content
Search AI Powered

Latest Stories

NY Cannabis Not as Potent as It Claims to Be According to New Research

NY Weed contains drastically lower THC than advertised
NY Weed contains drastically lower THC than advertised

A recent experiment conducted by NY Cannabis Insider has led to a statewide policy change in New York State regarding the testing and labeling of legal recreational cannabis products. The experiment involved purchasing the eight highest-potency strains of legal recreational cannabis available in the state and submitting them for potency testing at a state-certified laboratory. The results showed that the majority of the products available on the market contained significantly lower THC levels than advertised:

  • One strain showed 33.8% THC on the consumer-facing label, while testing said the actual number was 21.7%
  • The lab found another product contained 17.7% THC, while its label advertised 28.5% – a roughly 47% difference
  • Only three samples came within a 10% margin of error from their labeled potency, which is more or less the variance state regulators are proposing be allowed for the New York industry
  • Only one out of the five brands had gone through testing for state-certified potency, and its strength was almost exactly what the label stated.

The discrepancy between the labeled and actual potency of the products was due to a government band-aid called line testing, which allows flower and pre-rolls to be sold without measuring actual potency and instead advertise "anticipated potency". 


This policy has now been changed by the Office of Cannabis Management (OCM), which has concluded that the state's flower "should be tested for potency" and has announced an end to its line testing program for flower and pre-rolls.

The OCM also stated that it is updating its testing protocols due to a greater than expected variability of potency testing for flower, and will constantly monitor data and update standards and protocols to reflect the findings. The policy change affects every cannabis grower, processor, and consumer in the state.

“Cannabis consumers have a right to rely on the accuracy of packaging and labeling, and manufacturers and marketers have a duty to ensure the safety of their products and the accuracy of the representations on their labels,” Sheri Tarr, the chief advisor of cannabis consulting firm '68 Partners told NY Cannabis Insider.

The experiment conducted by NY Cannabis Insider has highlighted the need for proper testing and labeling of cannabis products to ensure the safety and accuracy of information for consumers. 

The policy change by the OCM is a step in the right direction towards creating a more transparent and accountable cannabis market in New York State.

More For You

Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
Lights, Camera, Cannabis: The New Theater Experience
Cigar smoking in a bar....
Giphy

NY Movie Theaters: High on Cannabis Lounges

In the dimly lit ambiance of New York City's historic movie theaters, the scent of buttered popcorn has long been the olfactory hallmark. However, as cannabis legalization sweeps across the state, a provocative question emerges: Could the future of cinema include the aroma of cannabis alongside the traditional concessions?

The Current Landscape of Cannabis Consumption Lounges

New York State’s Clean Indoor Air Act (CIAA) casts a long shadow over this budding idea. Enacted to safeguard public health, the CIAA prohibits smoking and vaping in most indoor workplaces, encompassing bars, restaurants, and, notably, movie theaters. The act defines smoking expansively, including the burning of tobacco, cannabis, or cannabinoid-hemp products. Violations can result in fines up to $2,000 for each infraction, underscoring the state’s commitment to maintaining smoke-free public spaces.

Keep ReadingShow less
80s anti-drug ad, egg cooking in frying pan, indicates your "brain on drugs"
DEA's 2025 'Anti-420 Day' Campaign: A Misguided Step Backward
Giphy

DEA's Anti-420 Fail

In a move that seems more like a relic from the “Just Say No” era than a contemporary public health initiative, the Drug Enforcement Administration (DEA) is backing an “Anti-420 Day” campaign aimed at recruiting high school and college students to produce anti-cannabis content for Instagram. This initiative, which also aims to address drug abuse among high school and college students by highlighting its impact on education and behavior, is spearheaded by the anti-cannabis nonprofit Johnny’s Ambassadors. It offers modest incentives—$25 to $50 Amazon gift cards—for videos warning peers about the purported dangers of THC use.

A Disconnect from Current Drug Policy Realities

At a time when more than 23 states have embraced full cannabis legalization and public opinion has shifted significantly in favor of reform, the DEA’s endorsement of this campaign appears tone-deaf and regressive. The agency’s attempt to “flood” social media with anti-THC messages not only disregards the evolving legal landscape but also undermines efforts toward normalization and informed discourse surrounding cannabis use. A multifaceted approach to drug abuse prevention, which includes increased resources for prevention and rehabilitation, is necessary to address the complexities of drug addiction. This contrasts sharply with the DEA's current strategies that emphasize law enforcement and interdiction over public health-focused measures.

Keep ReadingShow less
Talking Joints Memo - Chris Faraone
Talking Joints Memo - Chris Faraone

Massachusetts State Lawmakers Release Scathing Critique of MA's Cannabis Control Commission

By Chris Faraone, Talking Joints Memo. Reprinted with permission from Talking Joints Memo. .

“The public deserves some accountability on why these issues have proven so hard to stamp out, and what long-term changes the agency is making to get its work done with more transparency and efficiency.”

There has been endless drama around the Massachusetts Cannabis Control Commission over the past few months, all of which is only heightening in the wake of state Treasurer Deb Goldberg suspending the agency’s chairwoman last week.

Keep ReadingShow less